Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #1,471 to #1,520.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Fission → Nuclear fission
  2. NUMB → Numb
  3. Numerical instability → Numerical stability
  4. EUROACTION → Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme
  5. Nutritionists → Nutritionist
  6. OASIS-6 – GIK → Oasis-6 – Glucose-Insulin-Potassium
  7. OAT → Occluded Artery Trial
  8. ESPRIT HRT → Oestrogen In The Prevention Of Reinfarction Trial
  9. OVERTURE → Omapatrilat Versus Enalapril Randomized Trial Of Utility In Reducing Events
  10. OCLA → Omeprazole Clopidogrel Aspirin
  11. Ommatidia → Ommatidium
  12. The Origin of Species → On the Origin of Species
  13. Oxyphilic adenoma → Oncocytoma
  14. ONTARGET → Ongoing Telmisartan Alone And In Combination With Ramipril Global Endpoint Trial
  15. On-TIME 2 → Ongoing Tirofiban In Myocardial Infarction Evaluation 2 Trial
  16. ON-TIME → Ongoing Tirofiban In Myocardial Infarction Evaluation Trial
  17. OPALS → Ontario Prehospital Advanced Life Support
  18. Inoperable → Operability
  19. Early spider orchid → Ophrys sphegodes
  20. Didelphimorphia → Opossum
  21. ODESSA → Optical Coherence Tomography For Des Safety
  22. Fiber optics → Optical fiber
  23. Fiber optic → Optical fiber
  24. OPUS → Optimal Angioplasty Versus Primary Stenting
  25. OARS → Optimal Atherectomy Restenosis Study
  26. OCBAS → Optimal Coronary Balloon Angioplasty With Provisional Stenting Vs. Stent Trial
  27. Editing Optimal Medical Therapy or PCI: Occluded Artery Trial (OAT) Reveals the More Cost-Effective Treatment → Optimal Medical Therapy or PCI: Occluded Artery Trial (OAT) Reveals the More Cost-Effective Treatment
  28. OPTIC → Optimal Pharmacological Therapy In Cardioverter Defibrillator Patients Trial
  29. ODIXa-HIP → Oral, Direct Factor Xa Inhibitor, Bay 59-7939, Given Once Daily In Patients Undergoing Total Hip Replacement
  30. Oral Thrush (patient information) → Oral Candidiasis (patient information)
  31. ODIXa-DVT → Oral Direct Factor Xa Inhibitor Bay 59-7939 In Patients With Acute Symptomatic Deep-Vein Thrombosis
  32. ORBIT → Oral Glycoprotein IIb/IIia Receptor Blockade To Inhibit Thrombosis
  33. OSIRIS → Oral Sirolimus To Inhibit Recurrent In-Stent Stenosis
  34. ORAR II → Oral Treatment Of Restenosis
  35. TIMI 16-OPUS → Orbofiban In Patients With Unstable Coronary Syndromes, Thrombolysis In Myocardial Infarction
  36. OASIS-6 → Organization For The Assessment Of Strategies For Ischemic Syndromes 6
  37. OASIS-1 → Organization To Assess Strategies For Ischemic Syndromes
  38. Oscar Minkowski → Oskar Minkowski
  39. Otto Warburg → Otto Warburg (botanist)
  40. OPTIME-CHF → Outcomes Of A Prospective Trial Of Intravenous Milrinone For Exacerbations Of Chronic Heart Failure
  41. OPT-CHF → Oxypurinol Compared With Placebo For Class III-Iv Nyha Congestive Heart Failure
  42. User talk:Shivnkor → P90x
  43. PCI Complications: Radiocontrast toxicity → PCI Complications: Renal Failure#Toxicities Associated with Radiocontrast Agents
  44. Heparin-associated thrombocytopenia → PCI Complications: Thrombocytopenia#Heparin-Associated and Heparin-Induced Thrombocytopenia
  45. PCI in the Patient Requiring CPR and Refractory Ventricular Arrhythmias → PCI in the patient requiring CPR and refractory ventricular arrhythmias
  46. PCI in the Sole Remaining Conduit → PCI in the sole remaining conduit
  47. Coronary angiography PERFUSE thrombus grade 4 case studies → PERFUSE thrombus grade 4 case studies
  48. PASE → Pacemaker Selection In The Elderly
  49. ISAR DIABETES → Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent For The Prevention Of Restenosis In Diabetic Patients With Coronary Artery Disease
  50. TAXUS V ISR → Paclitaxel-Eluting Stents Vs. Brachytherapy For In-Stent Restenosis

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:BrokenRedirects"